Experts discuss dengue fever prevention in Vietnam
October 01, 2024 | 17:04
Takeda, a global biopharmaceutical company, hosted meetings in Ho Chi Minh City and Hanoi on September 26-27 to discuss a dengue prevention strategy.
Takeda’s decade of healthcare commitments in Vietnam
September 24, 2024 | 15:00
Dion Warren, Takeda’s area head for India and Southeast Asia, talked to VIR’s Bich Thuy about the company’s journey and its plans to bring more innovative medicines to Vietnam.
Takeda's commitment to health equity and access for rare disease community
March 28, 2024 | 17:05
This year's Rare Disease Day, February 29, served as a momentous occasion to celebrate the extraordinary journeys of rare disease patients and their devoted caregivers.
Experts come together to enhance dengue prevention strategies in Vietnam
September 30, 2023 | 09:00
On September 28, Takeda Pharmaceuticals, in collaboration with The Pasteur Institute in Ho Chi Minh City, held a conference on dengue fever prevention.
Programme launched to strengthen treatment for hereditary angioedema in Vietnam
December 08, 2021 | 18:30
Takeda and stakeholders have launched a programme to establish diagnostic methods, strengthen treatment, and develop guidelines for hereditary angioedema.
Mobile Version